The hERG activator RPR260243 abbreviated action potential duration and increased refractoriness, rescuing induced ventricular arrhythmia in a zebrafish heart model.
The hERG activator RPR260243 demonstrates antiarrhythmic potential by abbreviating action potential duration and increasing refractoriness in a zebrafish heart model.
hERG channel dysfunction causes long QT syndrome and arrhythmia. Activator compounds have been of significant interest due to their therapeutic potential. We used the whole organ zebrafish heart model to demonstrate the antiarrhythmic benefit of the hERG activator, RPR260243. The activator abbreviated APD and increased refractoriness, the combined effect of which rescued induced ventricular arrhythmia. Our findings show that the targeted slowing of hERG channel deactivation and enhancement of protective currents caused by the RPR260243 activator may provide an effective antiarrhythmic approach.
Shi et al. (Fri,) conducted a other in Ventricular arrhythmia. RPR260243 was evaluated on Action potential duration (APD), refractoriness, and induced ventricular arrhythmia. The hERG activator RPR260243 abbreviated action potential duration and increased refractoriness, rescuing induced ventricular arrhythmia in a zebrafish heart model.